Navigation Links
Ginkgo No Shield Against Alzheimer's
Date:11/18/2008

eloped dementia, and 92 percent of those cases were classified as possible or probable Alzheimer's disease.

Overall, the dementia rate for those taking ginkgo was 3.3 per 100 person-years of follow-up versus 2.9 per 100 person-years for the placebo group.

"If you're in your 70s or 80s, and you're contemplating taking ginkgo to prevent Alzheimer's or dementia, the idea that it can prevent these is not true," said DeKosky, who is vice president and dean of the University of Virginia School of Medicine in Charlottesville.

But, said DeKosky, the good news from this study is that there appear to be "no major problems for safety" where ginkgo is concerned.

However, the author of an accompanying editorial in the same issue of the journal, Dr. Lon Schneider, director of the State of California Alzheimer's Disease Research and Clinical Center at the University of Southern California in Los Angeles, pointed out that for people with a history of cardiovascular disease, there was an increased risk of hemorrhagic stroke in the group taking ginkgo, though the difference didn't reach statistical significance. Eight people in the placebo compared to 16 in the ginkgo group had a hemorrhagic stroke, Schneider noted.

He also pointed out that at least one smaller trial found an increased risk of the more common type of stroke, ischemic stroke, and transient ischemic attacks, in people taking ginkgo.

"In the absence of efficacy, people should be fairly careful about taking a drug anyway, and here, we've seen no evidence for potential gain, and there's some reason to be concerned about its use in the long term," said Schneider.

More information

Learn more about ginkgo from the U.S. National Center for Complementary and Alternative Medicine.



SOURCES: Steven T. DeKosky, M.D., vice president and
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Ginkgo Biloba Might Not Preserve Memory in Octogenarians
2. Football helmet shields can protect against a kick in the face
3. Anthem Blue Cross and Blue Shield in Connecticut Ranks in Top 10 of Insurers Nationwide on U.S. News & World Report/National Committee for Quality Assurance Americas Best Health Plans List
4. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
5. Anthem Blue Cross and Blue Shield Foundation Awards $100,000 Grant to Shoreline Greenway Trail
6. Anthem Blue Cross and Blue Shield in Maine Among Top Insurers on U.S. News & World Report/National Committee for Quality Assurance Americas Best Health Plans List
7. American Lung Association of Nevada Receives $150,000 Grant from Anthem Blue Cross and Blue Shield Foundation to Help Nevadas Youth Stay Smoke-Free
8. Anthem Blue Cross and Blue Shield in Maine Ranks in Top 6% of all insurers on U.S. News & World Report/National Committee for Quality Assurance Best Health Plans List
9. Live Event and Webcast: Blue Cross and Blue Shield Association Spearheads Major Initiative to Improve Healthcare Quality, Increase Cost Efficiency
10. Medicare Beneficiaries Can Suit Up, Sweat, and Learn About Blue Shields Medicare Advantage Plans at Local Malls and Senior Centers
11. Blue Cross Blue Shield of Michigan Closes Detroit Operations October 31 Due to Bomb Threat

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ginkgo No Shield Against Alzheimer's
Ginkgo No Shield Against Alzheimer's
(Date:11/9/2009)...e funds to move lab findings into human therapy fo...from nerve damage ,, ANN ARBOR, Mich., Nov. 9 ...versity of Michigan Department of Neurology have r...erapy for neuropathic pain, a difficult-to-treat c... of damage to nerve without obvious tissue injury....
(Date:11/9/2009)...e in French . , , Montreal, November 9, 2009...ale. In human bodies trillions of cells are couple...re composed. Yet these don,t come in twos, they a...use these complex cell networks are the backbone o... for ways to splice cell clusters down to their or...
(Date:11/9/2009)... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl...nounced the availability of INTUNIV (guanfacine) E...nited States for the treatment of Attention-Defici...olescents ages 6 to 17. INTUNIV, a once-daily for...cheduled alpha-2A receptor agonist approved for th...
(Date:11/9/2009)...ple around the world suffer from cataracts. Thomas...his coauthors discuss cataract surgery with the im...sue of Deutsches rzteblatt International ( Dtsch...ndness is usually due to opacification of the lens...rations are performed each year. Cataracts can be ...
(Date:11/9/2009)... people have tried to read Charles Darwin,s "Origi...0th anniversary this month, but gave up. , For t...k is about, help by way of a new book is at hand. ...eznick is the author of "The Origin Then and N...s " (Princeton University Press, 2009), which mak...
Breaking Medicine News(10 mins):Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2
...disorders among adolescent girls and boys can have...ead to dangerous weight-control behaviors, such as...t pills to control weight. The middle school age i... at the Harvard School of Public Health (HSPH) set...
...d number of youth with office visits with a diagno...tween 1994 and 2003, while adult visits with a bip... according to a report in the September issue of A...a (an abnormally elevated mood) and depression. Al...
... "Psoriasis Cure,Now," a nonprofit patient advoca... parents of children with psoriasis as their kids ...e fact sheet on children,s psoriasis,that parents ...discussing how to treat psoriasis in children and ...
...er 3 KFH has announced that it,has succeeded in o...SO,9001:2000 quality management systems with the B... Director, Dr Sally Sennitt, MD, says: "We are del...d,one that very few young medical device companies...
... data about the safety of drug-,eluting stents (DE...,patients with cardiovascular disease, according t...nterventions (SCAI). These new findings,also under...gimen of medications that prevent blood clots in t...
...fforts to control population growth in the present...s in the future. , This prediction comes from a S...r who spent a year in China studying its geriatric...niversity, said Chinas 1979 policy of limiting cou...
Other Medicine News:Health News:School-based overweight prevention program may cut risk of eating disorders among girls 2Health News:Study documents rapid increase in youth bipolar disorder diagnoses 2Health News:Psoriasis Cure Now offers 'Back to School' Resources for Parents of Children with Psoriasis 2Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 2Health News:Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up 3Health News:China's 1-child policy could backfire on its elderly 2Health News:China's 1-child policy could backfire on its elderly 3
(Date:11/9/2009)...ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today...epreve(TM) (bepotastine besilate ophthalmic soluti...were presented in poster sessions at the 2009 Annu...hma & Immunology (ACAAI) in Miami Beach, FL. ...of Ocular Itching with Bepotastine Besilate Ophtha...
(Date:11/9/2009)...ll/ -- Arcadia Resources, Inc. (NYSE Amex: KAD ),...care services under the Arcadia HealthCare(SM) bra...f Directors. Goldsmith will replace Tres Lund who..., (Photo: http://www.newscom.com/cgi-bin/prnh/20...aul Professor of Government and Director of Innova...
(Date:11/9/2009)...ia/ -- Chindex International, Inc.,("Chindex") (Na...ider of Western,healthcare products and services i...results for the second quarter and first half of f... Financial Highlights:, -- Revenue in the seco...on, a year over year basis;, -- Net incom...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Study of agricultural watersheds and carbon losses 8933 1Study of agricultural watersheds and carbon losses 8933 2Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution 8931 1Domestication of Capsicum annuum chile pepper provides insights into crop origin and evolution 8931 2Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 1Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 2Children 26apos 3Bs National Medical Center Dedicates New Blood Donor Center 49506 3
...euticals, Inc. (Nasdaq: ARNA ) announced today th...rial of APD125 in patients with primary,insomnia. ...na with the,potential to reduce insomnia symptoms ...hase 2b trial of APD125 is a double-blind, randomi...ng the efficacy and tolerability of,APD125 in pati...
...Navigenics, a,genetic health services company, tod... analysis. The Mayo Clinic study will examine how ...y a Navigenics genetic risk,assessment. The resear...etic assessments and the impact of such informatio...Proof of Principle Trial of Communication to,Patie...
Other Medicine Technology:Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5Navigenics'(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: